Mackness_2002_Eur.J.Clin.Invest_32_259

Reference

Title : Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls - Mackness_2002_Eur.J.Clin.Invest_32_259
Author(s) : Mackness B , Durrington PN , Boulton AJ , Hine D , Mackness MI
Ref : European Journal of Clinical Investigation , 32 :259 , 2002
Abstract :

BACKGROUND: The oxidation of low-density lipoprotein (LDL) is central to current theories on the initiation and progression of atherosclerosis. Type 1 diabetes is associated with an increase in oxidative stress, which may be responsible for the increased susceptibility to coronary heart disease seen in type 1 diabetes. High-density lipoprotein (HDL) associated paraoxonase (PON1) can retard the oxidation of LDL. DESIGN: Paraoxonase activity, concentration and genotype were therefore investigated in 152 people with type 1 diabetes and 282 healthy controls. These parameters were also investigated in the group with type 1 diabetes in relation to the presence of diabetic complications.
RESULTS: Both PON1 activity and concentration were significantly lower by 16.7% and 19.2% (both P < 0.05) in the type 1 diabetes group. These differences were independent of the PON1 coding region polymorphisms. The distribution of PON1 activity and mass were the same in both populations, i.e. for the PON1-192 polymorphism RR > RQ > QQ and for the PON1-55 polymorphism LL > LM > MM. There were no differences in either the PON1 polymorphisms, PON1 activity and concentration in people with type 1 diabetes in the presence or absence of micro and macro vascular complications of diabetes.
CONCLUSIONS: Low PON1 activity may contribute to the increased atherosclerosis found in type 1 diabetes by reducing the ability of HDL to retard LDL oxidation despite the frequently-found increased HDL in type 1 diabetes when good glycaemic control is established.

PubMedSearch : Mackness_2002_Eur.J.Clin.Invest_32_259
PubMedID: 11952811

Related information

Citations formats

Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI (2002)
Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls
European Journal of Clinical Investigation 32 :259

Mackness B, Durrington PN, Boulton AJ, Hine D, Mackness MI (2002)
European Journal of Clinical Investigation 32 :259